BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9129535)

  • 1. In vitro response of Plasmodium falciparum to atovaquone and correlation with other antimalarials: comparison between African and Asian strains.
    Gay F; Bustos D; Traore B; Jardinel C; Southammavong M; Ciceron L; Danis MM
    Am J Trop Med Hyg; 1997 Mar; 56(3):315-7. PubMed ID: 9129535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of atovaquone against the African isolates and clones of Plasmodium falciparum.
    Basco LK; Ramiliarisoa O; Le Bras J
    Am J Trop Med Hyg; 1995 Oct; 53(4):388-91. PubMed ID: 7485692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum.
    Basco LK; Le Bras J
    Am J Trop Med Hyg; 1993 Sep; 49(3):301-7. PubMed ID: 8372953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum.
    Basco LK; Le Bras J
    Am J Trop Med Hyg; 1992 Oct; 47(4):521-7. PubMed ID: 1443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
    Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A
    Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives.
    Bustos MD; Gay F; Diquet B
    Bull World Health Organ; 1994; 72(5):729-35. PubMed ID: 7955021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
    Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Agarwal P; Anvikar AR; Pillai CR; Srivastava K
    Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.
    Pradines B; Tall A; Rogier C; Spiegel A; Mosnier J; Marrama L; Fusai T; Millet P; Panconi E; Trape JF; Parzy D
    Trop Med Int Health; 2002 Mar; 7(3):265-70. PubMed ID: 11903989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
    Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
    East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liu R; Li G; Li M; Wang B; Zhang D; Xu L; Zhao L; Liao R; Xu Q; Bei Z-C; Song Y
    Microbiol Spectr; 2024 Jul; 12(7):e0063024. PubMed ID: 38780257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum.
    Gupta S; Thapar MM; Wernsdorfer WH; Björkman A
    Antimicrob Agents Chemother; 2002 May; 46(5):1510-5. PubMed ID: 11959589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.
    Canfield CJ; Pudney M; Gutteridge WE
    Exp Parasitol; 1995 May; 80(3):373-81. PubMed ID: 7729473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro.
    Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
    Parasitol Res; 1997; 83(5):489-91. PubMed ID: 9197398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
    Basco LK
    Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu).
    Doury JC; Ringwald P; Guelain J; Le Bras J
    Trop Med Parasitol; 1992 Sep; 43(3):197-8. PubMed ID: 1470842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.